Actively Recruiting
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Led by David M. Ritter · Updated on 2026-01-23
300
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is an observational registry designed to gather information about Tuberous Sclerosis Complex (TSC) and Lymphangioleiomyomatosis (LAM) in pregnant women and their child.
CONDITIONS
Official Title
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant woman with a clinical or genetic diagnosis of TSC based on 2021 Consensus Guidelines
- Pregnant woman diagnosed with LAM
- Pregnant woman with a variant of uncertain significance in TSC1 or TSC2 genes
- Pregnant woman whose fetus has a 50% chance of TSC as determined by the study team
- Pregnant woman whose fetus shows signs of TSC such as rhabdomyomas, tubers, or subependymal giant cell astrocytoma
- Infant born to an enrolled participant
You will not qualify if you...
- Pregnant woman without TSC who used preimplantation genetic testing for TSC unless fetus has 50% chance of TSC
- Infants diagnosed with TSC whose birth mother was not enrolled in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229
Actively Recruiting
Research Team
M
Molly S Griffith, BA
CONTACT
A
Adrienne Victory
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here